Zarrabian Saiid 4
4 · DelMar Pharmaceuticals, Inc. · Filed May 22, 2018
Insider Transaction Report
Form 4
Zarrabian Saiid
DirectorInterim CEO
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-21+836,465→ 836,465 totalExercise: $0.98Exp: 2028-05-21→ Common Stock (836,465 underlying)
Footnotes (1)
- [F1]1/6th of the options vest on November 21, 2018 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on December 21, 2018.